Patents
Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
03/2001
03/21/2001EP1083893A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d 1? receptors
03/21/2001EP1083888A1 MULTIBINDING AGENTS THAT MODULATE PPARgamma AND RXR RECEPTORS
03/21/2001CN1063446C Thienopyridine derivatives as gonadotropin releasing hormone antagonists
03/20/2001US6204261 Inhibitors of interleukin-1β Converting enzyme inhibitors
03/15/2001WO2001017516A2 Method of inhibiting protein tyrosine phosphatase 1b and/or t-cell protein tyrosine phosphatase and/or other ptpases with an asp residue at position 48
03/15/2001DE19943815A1 Verwendung von Thienopyrimidinen Use of Thienopyrimidinen
03/15/2001DE10017460A1 Verfahren zur Herstellung von Hexahydrothieno(3,4-d)imidazol-2,4-dionen A process for preparing hexahydrothieno (3,4-d) imidazole-2,4-diones
03/15/2001CA2318004A1 Novel polyamine analogues as therapeutic and diagnostic agents
03/14/2001EP1082289A1 Methods for identifying novel multimeric agents that modulate receptors
03/14/2001EP0781278B1 Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
03/14/2001CN1063179C Process for producing imidazodiazepine derivatives
03/13/2001USRE37094 Heterocyclic substituted acylaminothiazoles, their preparation and pharmaceutical compositions containing them
03/13/2001US6201004 Dioxino derivatives and their use as therapeutic agents
03/13/2001US6200932 As pesticide and herbicide
03/08/2001WO1999064047A8 Novel antiviral compounds
03/08/2001WO1999063930A8 Novel angiotensin receptor modulators and their uses
03/07/2001EP1081138A1 1,2-disubstituted 1,4-dihydro-4-oxoquinoline compounds
03/07/2001EP1081136A1 Optically active tetrahydrobenzindole derivatives
03/07/2001EP1080095A1 Modulators of protein tyrosine phosphatases (ptpases)
03/07/2001EP1080080A1 Novel therapeutic agents that modulate neurokinin receptors
03/07/2001EP1080068A1 Modulators of protein tyrosine phosphatases
03/07/2001EP1079821A1 Protease inhibitors
03/07/2001EP0734379B1 2-arylalkenyl-azacycloalkane derivatives as sigma receptor ligands, preparation method therefor and therapeutical use thereof
03/07/2001CN1286690A Compounds useful for inhibition of farnesyl protein transferase
03/07/2001CN1286683A Tetrahydrobenzindole derivs
03/07/2001CN1286255A Pyridine compounds, their preparation method and pharmaceutical compositions contg them
03/06/2001US6197785 Cardiovascular disorders
03/06/2001US6197225 Chromene compound
03/01/2001WO2001014381A1 Ether derivatives of pyrrolo[1,2-a]quinoxalines, method for producing them and their use in therapy
03/01/2001WO2001014380A1 Isomeric fused pyrrolocarbazoles and isoindolones
03/01/2001WO2001014358A2 Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benozopyrans
03/01/2001WO2001014344A2 Polycyclic pyrimidine-2,4(1h, 3h)-dione with functionalized alkyl radicals in 1- and/or 3-position, method for the production thereof and pharmaceutical preparations
03/01/2001WO2001014339A2 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
03/01/2001WO2001014333A1 Substituted piperidine compounds useful as modulators of chemokine receptor activity
03/01/2001CA2376275A1 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
02/2001
02/28/2001EP1078928A1 Pyridine derivatives, process for their preparation and pharmaceutical compositions containing them
02/28/2001EP1078261A1 Method for immobilising and/or crystallising biological macromolecules on carbon nanotubes and uses
02/28/2001EP1077978A1 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors
02/28/2001EP1077946A1 Fused tricyclic compounds which inhibit parp activity
02/28/2001EP1077944A1 Carboxamide compounds, compositions, and methods for inhibiting parp activity
02/28/2001EP1077928A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
02/28/2001EP1077927A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
02/28/2001CN1285834A Fused pyrazine compound
02/27/2001US6194449 Allosteric adenosine receptor modulators
02/27/2001US6194410 Antiserotonine agents; nervous system and psychological disorders
02/27/2001US6194409 Heterocyclic derivatives and their use as antithrombotic agents
02/27/2001US6194405 3,3a,8,12b-tetrahydro-n-methyl-2h-dibenzo(3,4:6,7)-cyclohepta( 1,2-b)-furan-2-methanamine, for example; anxiolytic agents, antidepressants, sleep and sexual disorders, psychological, cardiovascular and gastrointestinal disorders
02/27/2001CA2317053A1 New pyridine derivatives, the process for preparing them and the pharmaceutical compositions that contain them
02/27/2001CA2111204C Piperidine derivatives having anxiolytic effect
02/22/2001WO2001012603A1 Indole derivatives, process for their preparation, pharmaceutical compositions containing them and their medicinal application
02/22/2001WO2001012602A1 Condensed indoline derivatives and their use as 5ht, in particular 5ht2c, receptor ligands
02/22/2001WO2001012584A2 Pharmaceutical compounds
02/22/2001WO2001012197A1 Pyridomorphinans, thienomoprhinans and use thereof
02/22/2001WO2001011968A2 Heterocyclic spiro compounds as pesticides
02/22/2001WO1999063996A8 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
02/22/2001CA2698353A1 Pharmaceutical compounds
02/22/2001CA2381409A1 Nitric ester derivatives
02/22/2001CA2380814A1 Pyridomorphinans, thienomorphinans and use thereof
02/22/2001CA2377646A1 Indole derivatives, process for their preparation, pharmaceutical compositions containing them and their medicinal application
02/22/2001CA2377637A1 Condensed indoline derivatives and their use as 5ht, in particular 5ht2c, receptor ligands
02/21/2001CN1284944A Integrin receptor antagonists
02/21/2001CN1284868A Oral pharmaceutical pulsed release dosage form
02/21/2001CN1284866A Oral pharmaceutical extended release dosage form
02/21/2001CN1062268C Alcohol to azide SN2 conversion
02/20/2001US6191140 Potassium channel modulators; muscle relaxants; controlling cell membranes
02/20/2001CA2192289C Substituted heterocyclic derivatives
02/15/2001WO2001010847A2 Novel integrin receptor antagonists
02/15/2001WO2001010842A2 Melanocortin-4 receptor binding compounds and methods of use thereof
02/15/2001DE19940494C1 New fused 1- or 3-(mercaptoalkyl)-pyrimidine-2,4(1H, 3H)-dione derivatives, as stable collagenase inhibitors useful e.g. for treating rheumatism, tumor metastasis or sunburn
02/15/2001DE19936780A1 Neue Antagonisten von Integrinrezeptoren New antagonists of integrin
02/15/2001CA2381008A1 Melanocortin-4 receptor binding compounds and methods of use thereof
02/15/2001CA2379977A1 Novel integrin receptor antagonists
02/14/2001EP1075465A1 Arylphenyl-substituted cyclic keto enols
02/14/2001EP1021451A4 Asymmetric synthesis and catalysis with chiral heterocyclic compounds
02/14/2001CN1284079A Novel compounds
02/14/2001CN1284070A Alicyclic acylated heterocyclic derivatives
02/14/2001CN1284066A Substituted inidazole derivatives having agonist-like activity at alpha 2B or 2B/2C adrenergic receptors
02/14/2001CN1283995A Antiviral compounds
02/13/2001US6187910 Chelation compounds, radionuclide metal chelate compounds and radiolabeled targeting moieties formed therefrom, and methods of making and using these compounds, complexes and conjugates for diagnostic and therapeutic use
02/13/2001US6187788 Thieno(2,3-b)(dihydro)pyridine derivatives; gonadotropin-releasing hormone antagonists; anticarcinogenic agents; sexual and urogenital disorders
02/13/2001US6187777 Pyrrolo(3,2-d)pyrimidine derivatives; neuropeptide y and corticotropin releasing factor modulators; dietetics; antidiabetic, antiinflammatory, and antitumor agents
02/13/2001US6187774 Fused heterocyclic compounds and pharmaceutical applications thereof
02/08/2001WO2001009141A1 Polymerizable biotin derivatives, biotin polymer, and polymer responsive to avidin stimulation
02/08/2001WO2001009140A1 Thienopyranecarboxamide derivatives
02/08/2001WO2001009138A2 Chemokine receptor antagonists and methods of use therefor
02/08/2001WO2001009119A2 Chemokine receptor antagonists
02/08/2001WO2001009094A2 Chemokine receptor antagonists and methods of use therefor
02/08/2001WO2000058307A3 Aryl fused 2,4-disubstituted pyridines: nk3 receptor ligands
02/08/2001CA2391267A1 Chemokine receptor antagonists and methods of use therefor
02/08/2001CA2378302A1 Thienopyranecarboxamide derivatives
02/07/2001EP1073648A1 12,13-Modified epothilone derivatives
02/07/2001EP1073647A1 12,13-cyclopropane epothilone derivatives
02/07/2001EP1073435A1 Substituted tricyclic pyrazole derivatives with protein kinase activity
02/07/2001EP0799226B1 Tetracyclic spiro compounds, process for their preparation and their use as 5ht1d receptor antagonists
02/07/2001CN1283119A Pharmaceutical composition comprising ticlopidine and ginkgo biloba extract
02/07/2001CN1061658C Tricyclic benzazepine vasopression antagonists
02/06/2001US6184221 Antiarrhythmia agents, antiulcer agents
02/01/2001WO2001007436A2 Substituted oxoazaheterocyclyl compounds
02/01/2001WO2001007408A2 Novel method for preparing benzoperhydroisoindole compounds
02/01/2001CA2382755A1 Substituted oxoazaheterocyclyl compounds